medical_theme
Biotech Funding Cycles and Pharma MandA
♥ 2238 Thanks from members
Biotech funding cycles and pharma MandA are driven by structural patent cliffs, clinical trial attrition, and shifting cost-of-capital dynamics, creating a perpetual liquidity balancing act between venture capital, public markets, and big pharma pipelines.